Latest

By Dr Allan Pamba, Executive Vice President, Diagnostics, Africa at Roche Diagnostics Over many centuries, tuberculosis (TB) has travelled alongside humanity. Mycobacterium tuberculosis (MTB) is thought to have been around for millions of years and has had many names. In ancient Greece, it was called “phthisis”; in the 1700s, the “White Plague” and in the […]
...
Treatment regimens for drug resistant TB will see a price drop up to 29% The Stop TB Partnership’s Global Drug Facility (GDF) today announced price reductions up to 55% for bedaquiline, a critical drug used to treat drug-resistant TB (DR-TB). The new, reduced bedaquiline prices – secured through an open, competitive tender and valid through […]
...
By Violet Chihota Before COVID-19 came along, the two most lethal infectious diseases were HIV and tuberculosis (TB). Even though HIV still lingers, with 1.5 million people contracting the infection every year, epidemiologists point to the availability of many HIV prevention options as a primary reason for the decreasing caseload. According to the World Health Organization (WHO), over […]
...
Tuberculosis (TB) remains a major cause of ill health and one of the top 10 causes of death worldwide.1 a TB can affect anyone, anywhere – but it is also curable and preventable.1 b,c World TB Day falls on 24 March, and Sanofi is proud to announce the launch, in partnership with the Department of Health, of an […]
...